• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA Grants 510(k) Clearance to LivaNova’s B-Capta

    Gynesonics Appoints Susan Stimson to Its Board of Directors

    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump

    Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

    Abbott Begins Shipping Rapid COVID Self-Tests
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    MW Life Sciences

    K-Tube Technologies

    Concise Engineering

    Forefront Medical Technology
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS' Engineering Resources Increasingly in Demand

    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medicoil

    Unicep

    Trademark Plastics Inc.

    Forefront Medical Technology

    MW Life Sciences
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Grants Lucid Diagnostics Breakthrough Device Designation for Esophageal DNA Test

    Test is designed to facilitate the diagnosis of Barrett’s Esophagus, with and without dysplasia.

    Related CONTENT
    • Gynesonics Appoints Susan Stimson to Its Board of Directors
    • EMS' Engineering Resources Increasingly in Demand
    • Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    • FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Globe Newswire03.30.20
    PAVmed Inc., a differentiated, multiproduct medical device company, announced that the company’s majority owned subsidiary, Lucid Diagnostics Inc. has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its EsoGuard Esophageal DNA Test on esophageal samples collected using its EsoCheck Cell Collection Device in a prevalent well-defined group of patients at elevated risk for esophageal dysplasia due to chronic gastroesophageal reflux disease (GERD).
     
    “EsoGuard’s FDA Breakthrough Device designation represents a major milestone for PAVmed and Lucid,” said Lishan Aklog, M.D., PAVmed’s chairman and CEO and Lucid’s executive chairman. “This designation validates our belief that EsoGuard is a groundbreaking technology that has the potential to have as great an impact on esophageal cancer as widespread Pap screening has had in preventing deaths from cervical cancer. We look forward to working closely with the FDA to advance our EsoGuard in-vitro diagnostic (IVD) clinical development program at an expedited pace.”
     
    The FDA Breakthrough Device Program was created to offer patients more timely access to breakthrough technologies which “provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions” by expediting their development, assessment and review through enhanced communications and more efficient and flexible clinical study design, including more favorable pre/post market data collection balance. Breakthrough Devices receive priority FDA review, and a bipartisan bill before Congress (H.R. 5333) seeks to require Medicare to temporarily cover all Breakthrough Devices for three years while determining permanent coverage.
     
    ”I have dedicated my career to the care of patients across the disease spectrum from BE, with and without dysplasia, to lethal esophageal cancer, and have participated in some of the key developments in this field,” said Nicholas J. Shaheen M.D., MPH, professor of Medicine and Epidemiology and chief of the Division of Gastroenterology and Hepatology at UNC HealthCare, Director of the American College of Gastroenterology (ACG) Institute for Clinical Research and Education and lead author of its guidelines on the Diagnosis and Management of Barrett’s Esophagus. “I am very excited that the FDA deemed EsoGuard worthy of Breakthrough Device designation. This recognition significantly enhances EsoGuard’s potential to prevent deaths from esophageal cancer through early detection of these conditions.”
     
    “I am very gratified that FDA agreed with us that EsoGuard satisfies all of its criteria for Breakthrough Device designation for the proposed indications for use,” said Alberto Gutierrez, Ph.D., Lucid’s regulatory consultant and former director of the FDA's Office of In-Vitro Diagnostics (OIVD). “I have participated in the designation of several IVD Breakthrough Devices and understand the value this brings to Lucid’s clinical development program. I look forward to continuing to work with Lucid and FDA as we take advantage of the enhanced and accelerated FDA engagement opportunities granted to Breakthrough Devices.”
     
    The EsoGuard Esophageal DNA Test is performed on esophageal samples that are collected using Lucid’s FDA 510(k)-cleared EsoCheck Esophageal Cell Collection Device. These technologies were highlighted as one of the year’s significant advances in cancer prevention in the National Cancer Institute’s 2020 Annual Plan and Budget Proposal submitted to Congress. They are designed to facilitate the diagnosis of Barrett’s Esophagus (BE), with and without dysplasia—a progression of precursor conditions that culminate in highly lethal esophageal cancer (EAC)—as well as EAC itself, in patients with chronic heart burn, also known as gastroesophageal reflux disease (GERD).
     
    Although the ACG’s professional society practice guidelines recommend screening in millions of high-risk patients to detect and treat BE, with or without dysplasia, before it progresses to EAC, fewer than 10 percent actually undergo screening using the traditional invasive approach, upper endoscopy. Most patients diagnosed with EAC are neither aware of their underlying BE, nor that they missed the opportunity to undergo treatment which could have prevented progression to EAC had the BE been diagnosed earlier.
     
    As a result, over 80 percent die within five years of diagnosis. The estimated immediately addressable domestic market opportunity for EsoGuard is at least $2 billion based on very modest penetration of the United States GERD patients currently recommended for BE screening according to ACG guidelines.
     
    EsoGuard performs next generation sequencing (NGS) of bisulfite-converted DNA to detect methylation at 31 sites on two genes (VIM and CCNA1). EsoGuard has been shown in a 408-patient human study published in Science Translational Medicine to be highly accurate at detecting BE, with and without dysplasia, as well as EAC, with greater than 90 percent sensitivity and specificity.
     
    EsoGuard, which is already commercially available as a Laboratory Developed Test (LDT), is the subject of two Lucid-sponsored international multi-center IVD clinical trials in support of an FDA PMA. The screening study will enroll GERD patients without a prior diagnosis of BE or EAC who satisfy ACG BE screening guidelines. The case control study will enroll patients with a previous diagnosis of non-dysplastic BE, dysplastic BE (both low and high-grade) or EAC. In both studies, EsoGuard will be compared to the gold standard of endoscopy with biopsies. Dr. Shaheen serves as lead investigator for both studies, which will begin enrolling patients in the coming weeks at 60 sites in the United States and Europe.
    Related Searches
    • program
    • clinical trials
    • diagnostics
    • research
    Suggested For You
    Gynesonics Appoints Susan Stimson to Its Board of Directors Gynesonics Appoints Susan Stimson to Its Board of Directors
    EMS EMS' Engineering Resources Increasingly in Demand
    Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    Iterative Scopes Announces IBD-Focused Scientific Advisory Board Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Portable Medical Devices Market to Reach $100 Billion by 2027 Portable Medical Devices Market to Reach $100 Billion by 2027
    BD Receives 510(k) Clearance for Pristine Catheter BD Receives 510(k) Clearance for Pristine Catheter
    Endologix Acquires PQ Bypass Endologix Acquires PQ Bypass
    Elixir Medical Begins Study of Metallic Implant for CAD Treatment Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    CMS Establishes New Payment for Pelvalon’s Eclipse System CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Digging into the Cardiac Arrhythmia Monitoring Device Market Digging into the Cardiac Arrhythmia Monitoring Device Market
    J&J Vision, Menicon Begin Myopia Contact Lens Making Partnership J&J Vision, Menicon Begin Myopia Contact Lens Making Partnership
    Berlin Heals Berlin Heals' C-MIC Heart Failure Implant Achieves Breakthrough Device Status
    Philips Survey Reveals COVID-19’s Negative Impact on Sleep Quality, CPAP Use Philips Survey Reveals COVID-19’s Negative Impact on Sleep Quality, CPAP Use

    Related Breaking News

    • Patient Monitoring
      FDA Grants 510(k) Clearance to LivaNova’s B-Capta

      FDA Grants 510(k) Clearance to LivaNova’s B-Capta

      An in-line, blood-gas monitoring system integrated into the S5 Heart-Lung Machine.
      Charles Sternberg, Assistant Editor 04.20.21

    • Gynesonics Appoints Susan Stimson to Its Board of Directors

      Gynesonics Appoints Susan Stimson to Its Board of Directors

      Executive with extensive commercialization experience to provide key insights on global launch strategies.
      Michael Barbella, Managing Editor 04.20.21

    • Piezo Motion Debuts Piezoelectric Micro-Dosing Pump

      Piezo Motion Debuts Piezoelectric Micro-Dosing Pump

      Applications that traditionally require two or three separate laboratory devices can now be replaced with a single micro-dosing pump.
      Michael Barbella, Managing Editor 04.20.21


    • Cardiovascular
      Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

      Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

      Menlo Ventures, UCHealth invest to bring comprehensive hypertension measurement and management to the phone.
      Michael Barbella, Managing Editor 04.20.21

    • Diagnostics
      Abbott Begins Shipping Rapid COVID Self-Tests

      Abbott Begins Shipping Rapid COVID Self-Tests

      Abbott to manufacture tens of millions of BinaxNOW Self Tests per month.
      Sam Brusco, Associate Editor 04.20.21

    • Cardiovascular
      FDA OKs Canon Medical

      FDA OKs Canon Medical's One-Beat Spectral Cardiac CT

      Aquilion ONE / PRISM Edition now offers AI-powered spectral capabilities for cardiac exams.
      Sam Brusco, Associate Editor 04.19.21


    • NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite

      NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite

      Mobile Stroke Unit includes new CT scanner and features that help EMTs improve patient care.
      Michael Barbella, Managing Editor 04.19.21

    • IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System

      IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System

      Product has three programmable firing modes for tissue sampling.
      Michael Barbella, Managing Editor 04.19.21

    • Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development

      Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development

      Projects address infant feeding development, neonatal jaundice, pediatric dysphagia, unplanned extubations, and adrenal crisis.
      Michael Barbella, Managing Editor 04.19.21


    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board

      Iterative Scopes Announces IBD-Focused Scientific Advisory Board

      The governing body also will include experts in artificial intelligence.
      Michael Barbella, Managing Editor 04.16.21

    • Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

      Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

      Transaction is expected to foster the development of Vicarious Surgical's flagship robot and establish a foundation for long-term growth.
      Michael Barbella, Managing Editor 04.16.21

    • Diagnostics
      FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

      FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

      Assists physicians in detecting pre-cancerous growths, potentially addressing 19 million colonoscopies annually.
      Charles Sternberg, Assistant Editor 04.15.21


    • Acutus Medical Receives FDA Clearance of AcQCross

      Acutus Medical Receives FDA Clearance of AcQCross

      Product family targets more than 300,000 annual U.S. electrophysiology and structural heart procedures.
      Michael Barbella, Managing Editor 04.15.21

    • Thermo Fisher Scientific to Acquire PPD for $17.4 Billion

      Thermo Fisher Scientific to Acquire PPD for $17.4 Billion

      The deal establishes Thermo Fisher as a global leader in the high-growth clinical research services industry.
      Michael Barbella, Managing Editor 04.15.21

    • Portable Medical Devices Market to Reach $100 Billion by 2027

      Portable Medical Devices Market to Reach $100 Billion by 2027

      Sector to grow 8.5 percent annually over the next six years, driven by an increased awareness of overall health and fitness.
      Michael Barbella, Managing Editor 04.15.21


    Trending
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Harnessing Critical Health Data With Wearable Technology
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    • Gynesonics Appoints Susan Stimson to Its Board of Directors
    • Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    • Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology
    • Abbott Begins Shipping Rapid COVID Self-Tests
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Longvida Curcumin Extract Receives ANVISA Approval in Brazil
    Curcugen Curcumin Formulation Evidenced to Attenuate Post-Exercise Inflammation
    Good Rāz Launches Taste-Free Vitamin D3 Drops
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Releases Results of 2021 Green Building Community Survey
    PPG Publishes Sustainability Report
    Sherwin-Williams Launches Echelon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    Gynesonics Appoints Susan Stimson to Its Board of Directors
    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Evotec to Build Second Biologics Mfg. Facility in Toulouse
    Adare Pharma Names Ludger Roedder President of Adare Biome
    Johnson & Johnson 1Q Results
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Donginbi Launches Men’s Skincare Collection
    Kiehl’s Launches Pouch Refillables
    Skin Match Technology Partners with Men-Only Grooming Platforms
    Happi

    Latest Breaking News From Happi

    Robertet Appoints Reichert as Perfumer
    Kiehl’s Launches Sustainable Pouch Refillables for Hair Care, Skin Care
    New OTC Natural Hemp Pain Relief Gel Arrives at cbdMD
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PPG releases 2020 Sustainability Report
    GAA merges with AIMCAL
    Acucote expands Insights educational program
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Glatfelter GlatClean Nominated for World of Wipes Innovation Award
    P&G’s Sales Up 5%
    Ontex Tests Industrial Scale Diaper Composting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Spinal Elements' Lucent 3D Additive Manufactured Interbodies Earn FDA Nod
    Conformis, Paragon 28 Ink Licensing Deal
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints imec, Soitec Executives to Europe Advisory Board
    NREL Takes Novel Approach to 3D-Printed Water Power Prototypes
    Canatu Manufactures World’s Thinnest Free-standing CNB Membrane

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login